HB 500
Alternative Names: HB-500Latest Information Update: 05 Jul 2024
At a glance
- Originator Hookipa Pharma
- Class AIDS vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I HIV infections